Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule
Go back to Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule| (NASDAQ: LEXX) | Delayed: 0.56 -0.01 (1.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.57 | 52 Week High | $ | |||
| Open | $0.57 | 52 Week Low | $ | |||
| Day High | $0.60 | P/E | N/A | |||
| Day Low | $0.56 | EPS | $ | |||
| Volume | 48,948 | |||||

